Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Hematopoietic stem cells (HSCs) undergo self-renewing cell divisions and maintain blood production for their lifetime. Appropriate control of HSC self-renewal is crucial for the maintenance of hematopoietic homeostasis. Here we show that activation of p38 MAPK in response to increasing levels of reactive oxygen species (ROS) limits the lifespan of HSCs in vivo. In Atm(-/-) mice, elevation of ROS levels induces HSC-specific phosphorylation of p38 MAPK accompanied by a defect in the maintenance of HSC quiescence. Inhibition of p38 MAPK rescued ROS-induced defects in HSC repopulating capacity and in the maintenance of HSC quiescence, indicating that the ROS-p38 MAPK pathway contributes to exhaustion of the stem cell population. Furthermore, prolonged treatment with an antioxidant or an inhibitor of p38 MAPK extended the lifespan of HSCs from wild-type mice in serial transplantation experiments. These data show that inactivation of p38 MAPK protects HSCs against loss of self-renewal capacity. Our characterization of molecular mechanisms that limit HSC lifespan may lead to beneficial therapies for human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In another study, ROS-induced depletion of HSC was shown to be mediated by p38 MAPK phosphorylation in the ATM −/− cells [112].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [112]
In the citing paper
“Levels of ROS in cells may also be regulated by ataxia telangiectasia mutated (ATM) kinase, and age-related declines in expression of ATM can result in an increase in ROS in cells (77,78).”
From Causes, consequences, and reversal of immune system aging (2013) · cites this paper as [78]
In the citing paper
“age-dependent alterations in regulation of SOD2 by FoxO3 and the DNA damage sensing serine/threonine protein kinase ATM (ataxia-telangiectasia mutated) have been shown to contribute to loss of HSC function with aging11,16, 24.”
From Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) · cites this paper as [24]
In the citing paper
“NAC treatment restores the quiescence and reconstitution capacity of ATM-null HSCs24”
From Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) · cites this paper as [24]
In the citing paper
“high levels of reactive oxygen species, generated by mitochondria, accumulate in aged HSCs and compromise their functioning.”
From Aging of hematopoietic stem cells (2018) · cites this paper as [61]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388 · cited 1×
“Discussion Cell senescence is regulated primarily by increased oxidative stress as well as by telomere shortenin”
BackgroundMitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging
Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., Hofer, T., Seo, A. Y., Sullivan, R., Jobling, W. A., et al. (2005) · Science · doi:10.1126/science.1112125 · Cited by 2,165
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G. Y., & Suda, T. (2004) · Cell · doi:10.1016/j.cell.2004.07.004 · Cited by 1,974
Self-citationBmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871 · cited 1×
“Low doses of BSO increased expression of the tumor suppressors p16 Ink4a and p19 Arf , which induce loss of the HSC compartmen”
BackgroundExtension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724 · cited 1×
“, it is controversial whether increasing antioxidative defenses enhances longevit”
BackgroundInk4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486 · cited 1×
“The finding that p16 Ink4a is a biomarker of aging supports this ide”
BackgroundHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339 · cited 1×
“Although the ratio of cells in S, G2 or M phase was not altered in Atm −/− mice, the proportion of cells in G0 among Atm −/− KSL cells, as evaluated by Pyronin Y stainin”
MethodASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., & Ichijo, H. (2001) · EMBO reports · doi:10.1093/embo-reports/kve046 · Cited by 1,210 · cited 1×
“H 2 O 2 -induced activation of p38 MAPK is suppressed in MAP3k5 −/− cell”
BackgroundRegulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells
Ito, K., Hirao, A., Arai, F., Matsuoka, S., Takubo, K., Hamaguchi, I., Nomiyama, K., Hosokawa, K., Sakurada, K., Nakagata, N., et al. (2004) · Nature · doi:10.1038/nature02989 · Cited by 1,175 · cited 1×
“, for 2 d increased levels of hydroxyperoxide (H 2 O 2 ), which were measured by staining with 2′-7′-dichlorofluorescene diacetate (DCF-DA”
MethodSelf-citation
Cited by
Items 401–500 of 1,001
Maintenance of genomic integrity in hematopoietic stem cells
Naka, K., & Hirao, A. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0793-z · Cited by 75
“observation, it was reported that the exhaustion of HSCs that occurs during serial transplantation can be prevented by NAC treatment [ 10 ].”
BackgroundSelf-citationEffects of Triclosan on Neural Stem Cell Viability and Survival
Park, B. K., Gonzales, E. L., Yang, S. M., Bang, M., Choi, C. S., & Shin, C. Y. (2015) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.164 · Cited by 70
“For example, in hematopoietic stem cells (HSCs), increased ROS production phosphorylates the p38 MAPK to cause disruption of their quiescence which were reversed with an antioxidant or a p38 MAPK inhibitor (Ito et al., 2006).”
BackgroundLatchney, S. E., & Calvi, L. M. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.10.001 · Cited by 64
Xiao, H., Xiong, L., Song, X., Jin, P., Chen, L., Chen, X., Yao, H., Wang, Y., & Wang, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112265 · Cited by 69
“Cx43-deficient HSCs are prone to senescence because of their inability to transfer ROS to the HM leading to accumulation of ROS within HSCs [54].”
BackgroundRodrigues, M., Turner, O., Stolz, D. B., Griffith, L. G., & Wells, A. H. (2012) · Cell Transplantation · doi:10.3727/096368912x639035 · Cited by 64
“Activation of p38 MAPK by ROS on the other hand has been shown to kill and limit the population of hematopoietic stem cell in vivo (28).”
BackgroundRole of the polycomb group proteins in hematopoietic stem cells
Konuma, T., Oguro, H., & Iwama, A. (2010) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2010.01191.x · Cited by 73
“Similarly, mice conditionally depleted of FoxO1, FoxO3a, and FoxO4 in hematopoietic cells showed reduced HSC numbers and activity also associated with increased accumulation of ROS (Tothova et al. 2007).”
BackgroundInfluentialDragojlovic-Munther, M., & Martínez-Agosto, J. A. (2012) · Development · doi:10.1242/dev.074203 · Cited by 72
“This and several other studies consistently demonstrated a link between HSC proliferation/quiescence and intracellular oxidation status (Ito et al., 2006; Arai and Suda, 2007; Jang and Sharkis, 2007; Tothova et al., 2007), similar to our findings.”
ResultNitta, E., Yamashita, M., Hosokawa, K., Xian, M., Takubo, K., Arai, F., Nakada, S., & Suda, T. (2011) · Blood · doi:10.1182/blood-2010-08-297390 · Cited by 64
Self-citationThe axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells
Chen, C., Liu, Y., Liu, Y., & Zheng, P. (2009) · Cell Cycle · doi:10.4161/cc.8.8.8139 · Cited by 68
Baris, O. R., Klose, A., Kloepper, J. E., Weiland, D., Neuhaus, J. F. G., Schauen, M., Wille, A., Müller, A., Merkwirth, C., Langer, T., et al. (2011) · Stem Cells · doi:10.1002/stem.695 · Cited by 64
Hypercholesterolemia Induces Oxidant Stress That Accelerates the Ageing of Hematopoietic Stem Cells
Tie, G., Messina, K. E., Yan, J., Messina, J. A., & Messina, L. M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000241 · Cited by 62
“Taken together, we provide evidence that hypercholesterolemia can cause oxidant stress that accelerates the ageing and impairs the reconstitution capacity of HSCs. ( J Am Heart Assoc.”
BackgroundResultInfluentialResilient and resourceful: Genome maintenance strategies in hematopoietic stem cells
Bakker, S. T., & Passegué, E. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.09.007 · Cited by 64
“Atm-deficient mice display a contraction of the HSC pool with decreased self-renewal capacity and loss of quiescence, which ultimately leads to HSC exhaustion associated with the development of age-associated BMF syndrome and increased p16/p19 expression [35,36].”
BackgroundGao, M., Zhao, D., Schouteden, S., Sorci‐Thomas, M. G., Veldhoven, P. P. V., Eggermont, K., Liu, C., Verfaillie, C. M., & Feng, Y. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304006 · Cited by 69
“The hypoxic BM microenvironment is responsible for low ROS production in HSPCs, which is important for the maintenance of HSPC quiescence and self-renewal but not differentiation.(11) Comparison between ROS HSPCs and ROS HSPCs showed that the ROS population represents the quiescent HSPC population with self-renewal po…”
BackgroundInfluentialSilver nanoparticles cause complications in pregnant mice
Gurunathan, S., Zhang, X., Park, J. H., Choi, Y., Kang, M.-H., & Kim, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s95694 · Cited by 70
Inflammation and Prostate Cancer
Tewari, A. K., Stockert, J. A., Yadav, S. S., Yadav, K. K., & Khan, I. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-95693-0_3 · Cited by 68
Shen, H., Yu, H., Liang, P. H., Cheng, H., XuFeng, R., Yuan, Y., Zhang, P., Smith, C. A., & Cheng, T. (2012) · Blood · doi:10.1182/blood-2011-08-373621 · Cited by 62
Mas-Bargues, C., Viña-Almunia, J., Inglés, M., Sanz-Ros, J., Gambini, J., Ibáñez-Cabellos, J. S., García-Giménez, J. L., Viña, J., & Borrás, C. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.002 · Cited by 62
“Ito and colleagues described, both in vitro and in vivo, that activation of p16/pRb gene product pathway in response to elevated ROS led to the failure of hematopoietic stem cells (HSCs) function, and that treatment with antioxidant agents restored the constitutive capacity of HSCs, resulting in the prevention of bone…”
BackgroundThe Roles of Mitochondrial Dysfunction and Reactive Oxygen Species in Aging and Senescence
Zia, A., Farkhondeh, T., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Current Molecular Medicine · doi:10.2174/1566524021666210218112616 · Cited by 73
PI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling
Thürmer, M., Gollowitzer, A., Pein, H., Neukirch, K., Gelmez, E., Waltl, L., Wielsch, N., Winkler, R., Loeser, K., Grander, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30374-9 · Cited by 69
Veličković, L. J., & Stefanović, V. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0601-1 · Cited by 62
Noonin, C., Lin, X., Jiravanichpaisal, P., Söderhäll, K., & Söderhäll, I. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0077 · Cited by 62
“In mice, ROS were demonstrated to play a role in hematopoietic reconstitution [17], the HSC transition to myeloid progenitors, self-renewal capacity, and HSC quiescence maintenance [29,30].”
Oxidative stress: A dead end or a laboratory hypothesis?
Azzi, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.124 · Cited by 64
Acosta, S., Jernberg, J. N., Sanberg, C. D., Sanberg, P. R., Small, B. J., Gemma, C., & Bickford, P. C. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.1011 · Cited by 67
“29,30 It has clearly been demonstrated that circulating factors in the aged animal in-fluence stem cell function.”
Modeling of replicative senescence in hematopoietic development
Marciniak-Czochra, A. K., Stiehl, T., & Wagner, W. (2009) · Aging · doi:10.18632/aging.100072 · Cited by 64
The Emerging Role of Senescence in Ocular Disease
Sreekumar, P. G., Hinton, D. R., & Kannan, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2583601 · Cited by 61
Tan, S. W. S., Lee, Q. Y., Wong, B. S. E., Cai, Y., & Baeg, G. H. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.034 · Cited by 65
“Similarly, high ROS promote HSC differentiation by modulating p38 activity, thus limiting 350 Stem Cell Reports j Vol. 9 j 342–354 j July 11, 2017 HSC lifespan in mice (Ito et al., 2006).”
BackgroundThe cardiac hypoxic niche: emerging role of hypoxic microenvironment in cardiac progenitors.
Kimura, W., & Sadek, H. A. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2012.12.02 · Cited by 64
“In addition, what is the relationship between the hypoxic response (for example which occurs after myocardial infarction) and proliferation, migration and differentiation of GCPs in vivo? It is known that high ROS levels force other types of stem cells (such as HSCs) to exit from quiescence, spontaneously differentiat…”
BackgroundNutritional Regulation of Intestinal Stem Cells
Alonso, S., & Yilmaz, Ö. H. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051644 · Cited by 71
Wojtowicz, E. E., Lechman, E. R., Hermans, K. G., Schoof, E. M., Wienholds, E., Isserlin, R., van Veelen, P. A., Broekhuis, M. J. C., Janssen, G. M. C., Trotman-Grant, A., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.06.008 · Cited by 60
“These targets include p38 kinase, a negative HSC self-renewal regulator (Ito et al., 2006), and its inhibition leads to ex vivo HSC expansion (Wang et al., 2011), three protein tyrosine phosphatases (Ptpn1, Ptpn7, and Smek1, all known to suppress cytokine signaling and negatively regulate MAP…”
Nimer, S. D. (2008) · Hematology · doi:10.1182/asheducation-2008.1.43 · Cited by 68
Cellular and Molecular Mechanisms of Environmental Pollutants on Hematopoiesis
Scharf, P. R. D. S., Broering, M. F., da Rocha, G. H. O., & Farsky, S. H. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196996 · Cited by 68
“MAPK activation limits the lifespan of progenitor cells, and inhibition of p38 pathways protects the self-renewal capabilities of HSCs, avoiding their exhaustion and thus being a potential therapeutic target for improving the “stemness” of HSCs [79,86].”
BackgroundCellular Mechanisms of Somatic Stem Cell Aging
Jung, Y., & Brack, A. S. (2014) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416022-4.00014-7 · Cited by 61
“Deletion of DNA damage sensor Atm causes elevation of ROS, and loss of HSC quiescence, defects in repopulating capacity, and ultimately a depletion of the HSC pool (Ito et al., 2006).”
BackgroundGu, Q., Chen, C., Zhang, Z., Wu, Z., Fan, X., Zhang, Z., Di, W., & Shi, L. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.004 · Cited by 64
Wang, J., Morita, Y., Han, B., Niemann, S., Löffler, B., & Rudolph, K. L. (2016) · Nature Cell Biology · doi:10.1038/ncb3342 · Cited by 65
Evangelou, K., Bartkova, J., Kotsinas, A., Pateras, I. S., Liontos, M., Velimezi, G., Kosar, M., Liloglou, T., Trougakos, I. P., Dyrskjot, L., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.76 · Cited by 59
Erdem, A., Marín, S., Pereira‐Martins, D. A., Cortés, R., Cunningham, A., Pruis, M. G. M., de Boer, B., van den Heuvel, F. A. J., Geugien, M., Wierenga, A. T. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28737-3 · Cited by 66
“c Transcriptome data (log 2) retrieved from the Bloodspot site (GSE13159), comparison for PDK1, PDK2 and PDK3 in healthy HSC/MPP compared to AML with t(15;17), inv 16, t(8;21), t(11q;21) and complex phenotype (n= 252), and data are presented as mean by horizontal lines.”
MethodCurrent insights into the bone marrow niche: From biology in vivo to bioengineering ex vivo
Xiao, Y., McGuinness, C. S., Doherty-Boyd, W. S., Salmerón‐Sánchez, M., Donnelly, H., & Dalby, M. J. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121568 · Cited by 72
“ROS plays a role in activating numerous cellular signalling pathways, such as phosphoinositide 3-kinase (PI3K)/Protein kinase B (AKT) [133,136,137] and p38/mitogen-activated protein kinase (MAPK) [138], which are essential pathways for HSC maintenance.”
Kubo, M., Li, T., Suzuki, R., Shirasawa, B., Morikage, N., Ohshima, M., Qin, S., & Hamano, K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00856.2007 · Cited by 60
“Intracellular ROS levels were measured with the fluorescent probe 6-carboxyl-2 ,7 -dichlorodihydrofluorescein diacetate (DCF; Lambda Fluorescence Technology, Graz, Austria) as described previously (14).”
MethodLin, K. K., Rossi, L., Boles, N. C., Hall, B. E., George, T. C., & Goodell, M. A. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001148 · Cited by 69
“Serial competitive transplantations provide extreme proliferative stress for HSCs, in which the functional integrity of HSCs has to be delicately maintained and tightly controlled such that an imbalance of cell cycle progression (reviewed in [3]) or uncontrollable level of reactive oxygen species (ROS) [11] compromise…”
InfluentialJia, D., Koonce, N. A., Griffin, R. J., Jackson, C., & Corry, P. M. (2010) · Radiation Research · doi:10.1667/rr2030.1 · Cited by 59
“Although ROS have been shown to suppress the proliferation and differentiation capacity of hematopoietic progenitors and induce apoptosis of mature cells of the hematopoietic lineage (32,33), the sharp decrease in leukocyte counts in the peripheral blood after abdominal irradiation, a sign of hematopoietic suppression…”
Diabetes‐mediated myelopoiesis and the relationship to cardiovascular risk
Barrett, T. J., Murphy, A. J., Goldberg, I. J., & Fisher, E. A. A. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13462 · Cited by 63
Reactive Oxygen Species and Nrf2: Functional and Transcriptional Regulators of Hematopoiesis
Hu, L., Zhang, Y., Miao, W., & Cheng, T. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5153268 · Cited by 63
Chen, C., Mu, X., Zhou, Y. H., Ke, S., Geng, S., Liu, J., Wang, J., Chen, J., Li, T.-Y., & Wang, Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.136 · Cited by 61
Mattes, K., Vellenga, E., & Schepers, H. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102814 · Cited by 65
Targeting reactive oxygen species in stem cells for bone therapy
Li, X., Li, B., Shi, Y., Wang, C., & Ye, L. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.03.002 · Cited by 61
Fan, J., Cai, H., & Tan, W. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.05.023 · Cited by 59
“Recently, Keisuke Ito et al. (Ito et al., 2006) have shown that inactivation of p38 MAPK protected HSCs against loss of self-renewal capacity in vivo, which suggested the same importance of redox regulatory mechanisms in vivo.”
BackgroundMu, X., Zhang, Y., Li, J., Xia, J., Chen, X., Jing, P., Song, X., Wang, L., & Wang, Y. (2017) · Stem Cells International · doi:10.1155/2017/3508907 · Cited by 62
Kikuchi, S., Kobune, M., Iyama, S., Sato, T., Murase, K., Kawano, Y., Takada, K., Ono, K., Kaneko, Y., Miyanishi, K., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.006 · Cited by 56
Blockade of NADPH Oxidase Restores Vasoreparative Function in Diabetic CD34 + Cells
Jarajapu, Y. P. R., Caballero, S., Verma, A., Nakagawa, T., Lo, M. C., Li, Q., & Grant, M. B. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-70911 · Cited by 56
Cancer stem cells: A stride towards cancer cure?
Sengupta, A., & Cancelas, J. A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22213 · Cited by 56
“Oxidative stress can affect the self-renewal of long-term HSC by acting through the p38 MAPK pathway (Ito et al., 2006).”
BackgroundDNA Damage Response in Hematopoietic Stem Cell Ageing
Li, T., Zhou, Z.-W., Ju, Z., & Wang, Z.-Q. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.04.002 · Cited by 55
“For examples, knockout mice with defects in DNA DSB repair and quenching the ROS (such as Atm mice) or in resolving the replication fork stalls (knockout of Fancd2 pathway members) are ageing-prone and show defective hematopoiesis [51,55,56].”
BackgroundTasdogan, A., Kumar, S., Allies, G., Bausinger, J., Beckel, F., Hofemeister, H., Mulaw, M. A., Madan, V., Scharffetter‐Kochanek, K., Feuring‐Buske, M., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.007 · Cited by 59
Dynamic Interactions Between Cancer Stem Cells and Their Stromal Partners
Park, T. S., Donnenberg, V. S., Donnenberg, A. D., Zambidis, E. T., & Zimmerlin, L. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-013-0036-5 · Cited by 55
“The induction of oxidative stress disrupted the quiescence of leukemia–CSCs, leading to their entry into cycling and significant sensitivity to cytosine arabinoside and apoptosis [127].”
BackgroundHematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK pathway
Tesio, M., Tang, Y., Müdder, K., Saini, M., von Paleske, L., Macintyre, E., Pasparakis, M., Waisman, A., & Trumpp, A. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141438 · Cited by 55
“3 N), thus 532 Control of HSC function by CYLD–p38 | Tesio et al. inhibitor SB203580 (Ito et al., 2006).”
BackgroundInfluentialAccumulation of DNA damage in the aged hematopoietic stem cell compartment
Beerman, I. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.11.001 · Cited by 57
“are also associated with loss of functional potential (105).”
BackgroundOxidative stress regulates progenitor behavior and cortical neurogenesis
Chui, A., Zhang, Q., Dai, Q., & Shi, S. (2020) · Development · doi:10.1242/dev.184150 · Cited by 62
“Moreover, cellular ROS level varies between stem cells and differentiated cells, and has a contrasting effect on their transition and cell fate specification (Ito et al., 2004; Ito et al., 2006; Jang and Sharkis, 2007; Lee et al., 2018b; McGraw and Mittal, 2010; Owusu-Ansah and Banerjee, 2009; Sauer et al., 2001; Sing…”
BackgroundEmbryonic exposure of polystyrene nanoplastics affects cardiac development
Li, J., Weng, H., Liu, S., Li, F., Xu, K., Wen, S., Chen, X., Li, C., Nie, Y., Liao, B., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.167406 · Cited by 74
Stem Cell Senescence and Regenerative Paradigms
Beltrami, A. P., Cesselli, D., & Beltrami, C. A. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.262 · Cited by 54
Lymphoid differentiation of hematopoietic stem cells requires efficient Cxcr4 desensitization
Freitas, C., Wittner, M., Nguyen, J., Rondeau, V., Biajoux, V., Aknin, M.-L. R., Gaudin, F., Beaussant, S. C., Bertrand, Y., Bellanné‐Chantelot, C., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160806 · Cited by 61
“Both diminished HSC serial transplant capacity and aging phenotype have been causally associated with increased intracellular oxidation stress (Ito et al., 2006; Shao et al., 2011; Yahata et al., 2011).”
BackgroundIanniciello, A., Zarou, M. M., Rattigan, K. M., Scott, M. T., Dawson, A., Dunn, K. M., Brabcová, Z., Kalkman, E. R., Nixon, C., Michie, A. M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd5016 · Cited by 58
Iron overload and chelation therapy in myelodysplastic syndromes
Temraz, S. N., Santini, V., Musallam, K. M., & Taher, A. T. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.01.006 · Cited by 56
Proteasome activation enhances stemness and lifespan of human mesenchymal stem cells
Καπετάνου, Μ., Chondrogianni, N., Petrakis, S., Koliakos, G., & Gonos, E. S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.035 · Cited by 56
“Stem cells seem to be particularly sensitive to elevated ROS levels and treatment of HSCs with antioxidants [42] can increase their replicative potential.”
BackgroundPayandeh, Z., Tazehkand, A. P., Barati, G., Pouremamali, F., Kahroba, H., Baradaran, B., & Samadi, N. (2020) · Biochimie · doi:10.1016/j.biochi.2020.09.014 · Cited by 55
Cao, Y.-A., Wagers, A. J., Karsunky, H., Zhao, H., Reeves, R., Wong, R. J., Stevenson, D. K., Weissman, I. L., & Contag, C. H. (2008) · Blood · doi:10.1182/blood-2007-12-127621 · Cited by 53
Blood on the tracks: hematopoietic stem cell-endothelial cell interactions in homing and engraftment
Perlin, J. R., Sporrij, A., & Zon, L. I. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1559-8 · Cited by 52
SETD1A protects HSCs from activation-induced functional decline in vivo
Arndt, K., Kranz, A., Fohgrub, J., Jolly, A., Bledau, A. S., Virgilio, M. D., Lesche, M., Dahl, A., Höfer, T., Stewart, A. F., et al. (2018) · Blood · doi:10.1182/blood-2017-09-806844 · Cited by 53
Mitochondrial regulation in stem cells
Wang, Y., Barthez, M., & Chen, D. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.10.003 · Cited by 60
Genome instability of ageing stem cells—Induction and defence mechanisms
Burkhalter, M. D., Rudolph, K. L., & Sperka, T. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.004 · Cited by 53
IGF-1 rescues human intervertebral annulus cells from in vitro stress-induced premature senescence
Gruber, H. E., Hoelscher, G. L., Ingram, J. A., Bethea, S. F., & Hanley, E. N. (2008) · Growth Factors · doi:10.1080/08977190802273814 · Cited by 55
“Prolonged antioxidant treatment and administration or an inhibitor of p38 mitogen-activated protein kinase (MAPK) was shown by Ito et al. (2006) to protect hematopoietic stem cells from senescence.”
BackgroundBusada, J. T., Kaye, E. P., Renegar, R. H., & Geyer, C. B. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.114645 · Cited by 57
“The increased reactive oxygen species in differentiating cells as a result of oxidative metabolism are also linked to cellular differentiation [51, 52].”
BackgroundOxidative stress and myocarditis
Tada, Y., & Suzuki, J. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151222160559 · Cited by 59
Kong, Y., Song, Y., Hu, Y., Shi, M.-M., Wang, Y.-T., Wang, Y., Zhang, X., Xu, L., Liu, K., Deng, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8810 · Cited by 55
“This effect is reversible by treatment with the anti-oxidative drug N-acetyl-L-cysteine [18].”
BackgroundResultInfluentialSalidroside stimulates DNA repair enzyme Parp-1 activity in mouse HSC maintenance
Li, X., Sipple, J., Pang, Q., & Du, W. (2012) · Blood · doi:10.1182/blood-2011-10-387332 · Cited by 57
Niederkorn, M., Ishikawa, C., Hueneman, K. M., Bartram, J., Stepanchick, E., Bennett, J. R., Culver‐Cochran, A. E., Bolanos, L. C., Uible, E. E., Choi, K., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01394-z · Cited by 53
An aging-related immune landscape in the hematopoietic immune system
Lv, J., Zhang, C., Liu, X., Gu, C., Liu, Y., Gao, Y., Huang, Z., Jiang, Q., Chen, B., He, D., et al. (2024) · Immunity & Ageing · doi:10.1186/s12979-023-00403-2 · Cited by 56
“…modulators (such as TERT, APOE, and FGF21) [60–62], drugs (such as the mTOR inhibitor Rapamycin, Cdc42 inhibitor CASIN, and p38 MAPK inhibitor SB203580) [63–65], and BM niche changes [66] have been used to reverse the decline in HSC function due to aging, and have been shown to be effective.”
BackgroundZou, J., Zou, P., Wang, J., Li, L., Wang, Y., Zhou, D., & Liu, L. (2012) · Annals of Hematology · doi:10.1007/s00277-011-1397-7 · Cited by 50
“3a–c have already demonstrated that p38 inhibition does not inhibit HSC differentiation and activation of p38 has been implicated in the regulation of cell proliferation, apoptosis, and senescence, particularly in HSCs [31, 32].”
BackgroundHammoud, M., Vlaski‐Lafarge, M., Duchez, P., Chevaleyre, J., Lafarge, X., Boiron, J.-M., Praloran, V., de la Grange, P. B., & Ivanović, Z. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.23019 · Cited by 59
“On the other hand, the reactive oxygen species (ROS)molecules, exhibiting a harmful effect on primitive hematopoietic cells in terms of survival and function, are strongly generated in the culture at 20% O2 (Ito et al., 2006; Yahata et al., 2011).”
BackgroundWambi, C. O., Sanzari, J. K., Sayers, C. M., Nuth, M., Zhou, Z., Davis, J., Finnberg, N., Lewis-Wambi, J. S., Ware, J. H., El-Deiry, W. S., et al. (2009) · Radiation Research · doi:10.1667/rr1708.1 · Cited by 53
“Treatment of adult mice lacking the ataxia telangiectasia mutated gene (Atm2/2) with NAC or catalase not only prevents elevation in ROS but also results in partial rescue of bone marrow failure associated with increased chronic p38 MAPK-induced ROS (51, 52).”
BackgroundInfluentialMadonna, R., Novo, G., & Balistreri, C. R. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.03.005 · Cited by 54
Murine Bone Marrow Niches from Hematopoietic Stem Cells to B Cells
Aurrand‐Lions, M., & Mancini, S. J. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082353 · Cited by 62
“Furthermore, quiescent HSC identified by their capacity to retain EdU (5-ethynyl-2′-deoxyuridine) labelling in the long term, by their low levels of reactive oxygen species (ROS) or by their high expression of hypoxia-inducible transcription factor 1 (HIF-1α) [6,64,65], were found to be frequently located close to art…”
BackgroundStem Cells Use Distinct Self-renewal Programs at Different Ages
Levi, B. P., & Morrison, S. J. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.049 · Cited by 58
“2007) and damage from reactive oxygen species (Ito et al. 2006) accumulate with age in stem cells, impairing stem”
BackgroundDclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal
Chandrakesan, P., May, R. J., Qu, D., Weygant, N., Taylor, V. E., Li, J. D., Ali, N., Sureban, S. M., Qante, M., Wang, T. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5129 · Cited by 50
“In contrast, Atm deletion completely ablated the quiescent stem cell population in mouse bone marrow [34].”
BackgroundConcise Review: Leukemia Stem Cells in Personalized Medicine
Guzmán, M. L., & Allan, J. N. (2013) · Stem Cells · doi:10.1002/stem.1597 · Cited by 57
Zhang, C., Han, B.-J., Zeng, C.-C., Lai, S.-H., Li, W., Tang, B., Wan, D., Jiang, G., & Liu, Y. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.01.003 · Cited by 50
Reactive Oxygen Species and Metabolism in Leukemia: A Dangerous Liaison
Romo-González, M., Ijurko, C., & Hernández‐Hernández, Á. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889875 · Cited by 56
“In contrast, activation of p38 MAPK in response to oxidative stress impairs HSC function (34).”
BackgroundEvidence for Diversity in Transcriptional Profiles of Single Hematopoietic Stem Cells
Ramos, C. A., Bowman, T. V., Boles, N. C., Merchant, A. A., Zheng, Y., Parra, I., Fuqua, S. A. W., Shaw, C. A., & Goodell, M. A. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020159 · Cited by 56
“This is of particular relevance since recent reports have highlighted the importance of these pathways in the selfrenewal and control of life span of HSC [40,41].”
Goligorsky, M. S., Chen, J., & Patschan, S. A. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832a07bd · Cited by 52
Lin, C.-Y., Peng, C.-Y., Huang, T., Wu, M.-L., Lai, Y.-L., Peng, D. H., Chen, P.-F., Chen, H., Yen, B. L., Wu, K. K., et al. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0304 · Cited by 53
Cancer stem cells and angiogenesis
Bjerkvig, R., Johansson, M., Miletić, H., & Niclou, S. P. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.09.001 · Cited by 56
Effect of Ionizing Radiation Induced Damage of Endothelial Progenitor Cells in Vascular Regeneration
Lee, M.-O., Song, S., Jung, S.-Y., Hur, S., Asahara, T., Kim, S., Kwon, S., & Cha, H. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.237651 · Cited by 52
Cabrera-Serrano, A. J., Sánchez‐Maldonado, J. M., González‐Olmedo, C., Carretero-Fernández, M., Díaz-Beltrán, L., Gutiérrez‐Bautista, J. F., García‐Verdejo, F. J., Gálvez-Montosa, F., López-López, J. A., García-Martín, P., et al. (2025) · Antioxidants · doi:10.3390/antiox14030264 · Cited by 56
García‐Giménez, J. L., Gimeno, A., González‐Cabo, P., Dasí, F., Bolinches-Amorós, A., Mollá, B., Palau, F., & Pallardó, F. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020666 · Cited by 59
“We detected abnormal oxidative status and reduction of ATP in fibroblasts from all of them; by contrast, the molecular analysis of mitochondrial biogenesis signals showed two different patterns: while FRDA1 and FRDA2 samples showed increase expression of mtTFA transcription factor and the master regulator of mitochond…”
BackgroundInfluentialThe DNA damage response pathway in normal hematopoiesis and malignancies
Delia, D., & Mizutani, S. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2300-7 · Cited by 55
“It should be noted that ROS limit the lifespan of HSCs by inducing the activation of p38 MAPK and expression of p16Ink4a [20].”
BackgroundInflammation, a significant player of Ataxia–Telangiectasia pathogenesis?
Zaki‐Dizaji, M., Akrami, S. M., Azizi, G., Abolhassani, H., & Aghamohammadi, A. (2018) · Inflammation Research · doi:10.1007/s00011-018-1142-y · Cited by 50
Goswami, S. K., Maulik, N., & Das, D. K. (2007) · Annals of Medicine · doi:10.1080/07853890701374677 · Cited by 49
Implication of oxidative stress as a cause of autoimmune hemolytic anemia in NZB mice
Iuchi, Y., Kibe, N., Tsunoda, S., Suzuki, S., Mikami, T., Okada, F., Uchida, K., & Fujii, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.012 · Cited by 51
Lilly, A. J., Johnson, W. E. B., & Bunce, C. M. (2011) · Stem Cells International · doi:10.4061/2011/274564 · Cited by 65
“Other than causing cellular damage, data suggests that ROS activates the P38 MAPK pathway, which decreases adhesion molecule expression and enhances cell cycle progression [112, 114, 115].”
BackgroundBmi1 Confers Resistance to Oxidative Stress on Hematopoietic Stem Cells
Nakamura, S., Oshima, M., Yuan, J., Saraya, A., Miyagi, S., Konuma, T., Yamazaki, S., Osawa, M., Nakauchi, H., Koseki, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036209 · Cited by 51
“HSCs are exposed to various stresses including replicative and oxidative stresses during serial transplantation and eventually lose self-renewal capacity [16,17].”
BackgroundInfluentialHira, V. V. V., Noorden, C. J. F. V., Carraway, H. E., Maciejewski, J. P., & Molenaar, R. J. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.010 · Cited by 52
Gilchrist, A. E., Serrano, J. F., Ngo, M. T., Hrnjak, Z., Kim, S., & Harley, B. A. C. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.028 · Cited by 49
Metadata
- Authors
- Ito, K., Hirao, A., Arai, F., Takubo, K., Matsuoka, S., Miyamoto, K., Ohmura, M., Naka, K., Hosokawa, K., Ikeda, Y., & Suda, T.
- Affiliations
- Keio University (JP)
- Kanazawa University (JP)
- Corresponding author
- Hirao, Atsushi
- Suda, Toshio
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-03-26
- Volume
- 12
- Issue
- 4
- Pages
- 446-451
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1991962444
- Cited by
- 1,362
- References
- 21
- Citations by year
- 2026: 33 · 2025: 43 · 2024: 46 · 2023: 56 · 2022: 50 · 2021: 77 · 2020: 71 · 2019: 68 · 2018: 75 · 2017: 80 · 2016: 88 · 2015: 75 · 2014: 73 · 2013: 96 · 2012: 86
- FWCI
- 39.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, reactive oxygen species, p38 MAPK, HSC quiescence, HSC self-renewal, ATM deficiency, oxidative stress, antioxidant therapy, serial transplantation, hematopoietic homeostasis
- MeSH terms
- Animals, Cell Line, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Flow Cytometry, Hematopoietic Stem Cells, Imidazoles, Immunohistochemistry, Mice, Inbred C57BL, Phosphorylation, Pyridines, Up-Regulation, Free Radical Scavengers, Cellular Senescence, Reactive Oxygen Species, Oxidative Stress, Coculture Techniques, Cell Culture Techniques, Buthionine Sulfoximine, Reverse Transcriptase Polymerase Chain Reaction, Mice, Congenic, p38 Mitogen-Activated Protein Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.